Sipatrigine (BW 619C89) is a Neuroprotective Agent and a Sodium Channel and Calcium Channel Inhibitor

This publication has 68 references indexed in Scilit:

• Electrophysiology of Sipatrigine: A Lamotrigine Derivative Exhibiting Neuroprotective Effects
  Experimental Neurology, 2000
• Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
  Trends in Neurosciences, 1999
• An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons
  British Journal of Pharmacology, 1999
• Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI
  Neurology, 1998
• Determinants of the Time Course of Facilitation at the Granule Cell to Purkinje Cell Synapse
  Journal of Neuroscience, 1996
• A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia
  Brain Research, 1995
• Massive Persistent Release of Excitatory Amino Acids Following Human Occlusive Stroke
  Stroke, 1995
• Mediators of Injury in Neurotrauma: Intracellular Signal Transduction and Gene Expression
  Journal of Neurotrauma, 1995
• A Selective N-Type Ca²⁺-Channel Blocker Prevents CA1 Injury 24 h following Severe Forebrain Ischemia and Reduces Infarction following Focal Ischemia
  Journal of Cerebral Blood Flow & Metabolism, 1994
• Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.
  Stroke, 1986